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Insulin regulates glucose metabolism in adipocytes
via a phosphatidylinositide 3-kinase (PI3K)-dependent
pathway that appears to involve protein phosphoryla-
tion. However, the generation of phosphoinositides is
not sufficient for insulin action, and it has been sug-
gested that insulin regulation of glucose metabolism
may involve both PI3K-dependent and -independent
pathways, the latter being insulin specific. To test this
hypothesis, we have designed a phosphoprotein screen
to study insulin-specific phosphoproteins that may be
either downstream or in parallel to PI3K. Nineteen in-
sulin-regulated phosphospots were detected in the cy-
tosol and high speed pellet fractions, only six of which
were significantly regulated by platelet-derived growth
factor. Importantly, almost all (92%) of the insulin-spe-
cific phosphoproteins identified using this approach
were sensitive to the PI3K inhibitor wortmannin. Thus,
we obtained no evidence for an insulin-specific, PI3K-
independent signaling pathway. A large proportion
(62%) of the insulin-specific phosphoproteins were en-
riched in the same high speed pellet fraction to which
PI3K was recruited in response to insulin. Thus, our
data suggest that insulin specifically stimulates the
phosphorylation of a novel subset of downstream tar-
gets and this may in part be because of the unique lo-
calization of PI3K in response to insulin in adipocytes.
Insulin stimulates glucose uptake into muscle and fat cells
mainly through the translocation of glucose transporter 4
(GLUT4)1 from an intracellular location to the cell surface (1).
This mechanism is crucial for the maintenance of glucose ho-
meostasis. An impairment in insulin-stimulated glucose up-
take is a major factor leading to the development of non insu-
lin-dependent diabetes mellitus (2). Insulin binding to its cell
surface receptor activates the intrinsic tyrosine kinase activity
of the insulin receptor and stimulates tyrosine phosphorylation
of insulin receptor substrate proteins. Tyrosine-phosphorylated
IRS proteins in turn recruit Src homology 2 domain-containing
signaling proteins. Two main pathways have been identified
downstream of IRS proteins, the mitogen-activated protein
(MAP) kinase pathway and the phosphatidylinositide 3-kinase
(PI3K) pathway. The PI3K pathway, through protein kinase B
(PKB), has been shown to be necessary for insulin-stimulated
glucose transport through various experimental approaches.
First, two structurally unrelated inhibitors of PI3K, wortman-
nin and LY294002, potently inhibit insulin-stimulated glucose
transport in adipocytes (3, 4). Second, dominant negative mu-
tants of the p110 catalytic subunit (5), the p85 regulatory
subunit of PI3K (6), or PKB (7) inhibit insulin-stimulated glu-
cose transport in adipocytes. In addition, microinjection of a
PKB substrate peptide or an antibody to PKB inhibit insulin-
stimulated GLUT4 translocation in 3T3-L1 adipocytes (8). Fi-
nally, constitutively active PI3K (9) or PKB (10) trigger GLUT4
translocation independently of insulin when expressed in
adipocytes.
Whereas evidence supports a role for the PI3K/PKB pathway
in insulin-stimulated GLUT4 translocation in adipocytes, other
growth factors also activate PI3K without stimulating GLUT4
translocation, raising the question of signaling specificity (re-
viewed in Ref. 11). In particular, platelet-derived growth factor
(PDGF) stimulates PI3K activity to the same extent as insulin
in adipocytes but has relatively little effect on glucose transport
(12–17). Several hypotheses have been advanced to account for
this controversy. One possibility is that these different growth
factors may activate unique PI3K isoforms with different sub-
strate specificities. It has also been proposed that PI3K may be
activated in different locations in response to insulin versus
PDGF (13, 14, 18). Several studies have shown that in response
to PDGF, most of the increase in PI3K occurs in the plasma
membrane (PM) fraction. In contrast, following insulin stimu-
lation, there is a large increase in PI3K activity in a high speed
pellet (HSP) fraction. This fraction also contains the major
insulin regulatable IRS proteins (IRS1 and IRS2) found in
insulin-sensitive cells (13, 14, 18). One potential consequence of
this discrete localization is that PI3K may access different
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downstream targets. Alternatively, the activation of glucose
metabolism by insulin may require activation of the PI3K path-
way as well as an additional, insulin-specific pathway. The
finding that membrane-permeant analogs of phosphatidyli-
nositol 3,4,5-trisphosphate (PIP3) do not activate glucose up-
take when added to adipocytes suggests that activation of PI3K
may not be sufficient to stimulate GLUT4 translocation, lead-
ing to the hypothesis that a PI3K-independent pathway is also
required (19).
Each of these models predicts that insulin must trigger a
unique signal transduction pathway, that either lies down-
stream or in parallel to PI3K. Despite this prediction, little
progress has been made in elucidating such a novel pathway.
Thus, in the present study, we designed a subtraction assay
based on protein phosphorylation to select for molecules that
may be regulated in an insulin-specific manner. A differential
screening procedure using two-dimensional gels was employed
to select for phosphoproteins that are specifically regulated by
insulin, and not PDGF, in a wortmannin-sensitive manner.
Insulin stimulated the phosphorylation of 18 phosphoprotein
spots. Only six of these proteins were phosphorylated by PDGF
in a manner that was quantitatively comparable to insulin. In
addition, insulin specifically stimulated the dephosphorylation
of one row of phosphospots. Interestingly, insulin-specific phos-
phoproteins preferentially localized to the HSP fraction, fur-
ther confirming the presence of insulin-specific targets in this
fraction. With the possible exception of one phosphospot, all of
the insulin-specific phosphoproteins were wortmannin-sensi-
tive. Hence, based on these studies we have found no evidence
of an insulin-activated PI3K-independent pathway involving
protein phosphorylation in 3T3-L1 adipocytes. These results
suggest that insulin activates an unique, PI3K-dependent
pathway, which regulates metabolism in adipocytes.
EXPERIMENTAL PROCEDURES
Antibodies—Antibodies against mitogen-activated protein kinase
were described previously (20). Antibodies specific for mitogen-acti-
vated protein kinase phosphorylated at Thr202 and Tyr204 were from
New England Biolabs (Beverly, MA). Rabbit antibodies against PKBb
were generously provided by Dr. M. Birnbaum (Philadelphia, PA).
Generation of Phosphorylation Maps—For radiolabeling, 3T3-L1 adi-
pocytes were incubated in a buffer containing 12.5 mM HEPES, pH 7.4,
120 mM NaCl, 6 mM KCl, 1.2 mM Mg2SO4, 1 mM CaCl2, 0.2 mM NaPO4,
2% (w/v) bovine serum albumin, and 0.5 mCi/ml 32Pi (ICN) for 2 h at
37 °C. Labeled cells were then incubated with: 1) insulin (1 mM) for 15
min, 2) wortmannin (100 nM) for 25 min and wortmannin plus insulin
(1 mM) for a further 15 min, 3) PDGF bb (50 ng/ml, Life Technologies,
Inc.) for 15 min, or 4) no additions. After treatment, cells were washed
in ice-cold HES buffer (20 mM HEPES, pH 7.4, 1 mM EDTA, 250 mM
sucrose) and then homogenized in HES buffer supplemented with pro-
tease inhibitors (10 mg/ml aprotinin, 10 mg/ml leupeptin, and 1 mM
phenylmethylsulfonyl fluoride) and phosphatase inhibitors (1 mM so-
dium orthovanadate, 1 mM sodium pyrophosphate, 1 mM ammonium
molybdate and 10 mM sodium fluoride) by ten passes through a 22
gauge needle. Subcellular fractionation by differential centrifugation
was performed as described previously (21).
The PM and HSP pellets were directly solubilized in 2-DE sample
buffer (9 M urea, 40 mM Tris, 4.4% CHAPS, 84 mM dithiothreitol, 1%
Pharmalyte, 1 mM phenylmethylsulfonyl fluoride and phosphatase in-
hibitors as above). The cytosol fraction was precipitated with 4 sample
volumes of ice-cold acetone for 10 min and then centrifuged for 5 min at
10,000 3 g at room temperature. The resulting protein pellets were
solubilized in 2-DE sample buffer. Protein concentration was deter-
mined by the method of Bradford (Bio-Rad), and 150 mg of each fraction
was loaded onto the gel. 2-DE, silver staining, and autoradiography
were performed as described (21).
Analysis of Phosphorylation Maps—Autoradiographs were digitized
using a densitometer (Molecular Analyst, Bio-Rad), and analyzed using
Melanie II 2D analysis software (Bio-Rad). Detailed analysis was per-
formed on HSP and cytosol fractions obtained from basal, insulin-,
PDGF- and wortmannin-plus-insulin-treated cells from five separate
experiments. Gel spots were detected by the software and manually
checked. Spot intensity was measured as volumes (integration of optical
density over area) and then normalized to the overall volume for each
gel to account for gel-to-gel variations within each experiment. Gels
were aligned using dominant phosphoproteins present in all gels as
landmarks. Gel spots were matched across the four treatment groups
for each experiment by the software and then manually checked. The
normalized values for matched spots from basal versus insulin-treated
cells were compared for significant changes that were consistent be-
tween five experiments using paired t tests. Values for corresponding
spots were expressed as a percentage of the insulin-stimulated value, as
shown in Tables I and II. The molecular mass and pI of phosphoprotein
spots were calculated by the analysis software using the following
landmark proteins (mass/pI): actin, (42 kDa/5.29), a-enolase (47 kDa/
6.24), ATP-citrate lyase (ACL, 121 kDa/6.96), bovine serum albumin
(bovine serum albumin, 66 kDa), cytosolic malate dehydrogenase (36
kDa/6.16), elongation factor 2 (95 kDa/6.41), and vimentin (54 kDa/
5.06). Landmark proteins were identified by immunoblotting or
sequencing.
Immunoblot Analysis of Two-dimensional Gels—Proteins were
transferred to polyvinylidene difluoride membranes (Immobilon-P from
Millipore) according to the method of Towbin et al. (22). After blocking
nonspecific binding sites with 5% skim milk powder in Tris-buffered
saline/Tween (TBST, 50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Tween-
20), membranes were incubated with the relevant primary antibodies
diluted in blocking buffer for 2 h at room temperature or overnight at
4 °C. After washing in TBST, membranes were incubated with horse-
radish peroxidase-conjugated secondary antibody (Amersham Pharma-
cia Biotech) diluted 1/10,000 in TBST for 1 h at room temperature. After
washing in TBST, antibody bound was visualized using Supersignal
chemiluminescence substrate (Pierce) and Fuji film.
Preparative 2-DE and In-gel Tryptic Digestion—For sequence anal-
ysis of phosphoprotein spots, a combined cytosol 1 HSP fraction (6 mg)
from insulin-stimulated cells was subjected to SDS-polyacrylamide gel
electrophoresis. Regions between 35 and 55 kDa, and from 100 to 200
kDa were excised and electroeluted using a Bio-Rad electroeluter. The
eluate was concentrated in a speed-vac. SDS was removed by methanol-
chloroform precipitation (23), and the protein precipitate was resolubi-
lized in 2-DE sample buffer containing 7 M urea and 2 M thiourea.
Samples prepared from one preparative SDS-polyacrylamide gel elec-
trophoresis gel were combined with an aliquot of 32P-labeled cytosol 1
HSP fraction (150 mg) prepared from insulin-stimulated cells, and
loaded onto a two-dimensional gel. Preparative two-dimensional gels
were stained with Coomassie, dried, and subjected to autoradiography
to identify phosphoproteins of interest. As most phosphoprotein spots
were not stained by Coomassie, corresponding spots were excised from
multiple preparative two-dimensional gels and re-electrophoresed into
one band as described previously (24). Coomassie-stained bands were
excised and subjected to in-gel tryptic digestion (25).
Liquid Chromatography/Electrospray-Ion Trap Mass Spectrome-
try—An electrospray ion trap mass spectrometer (LCQ Finnigan MAT,
San Jose, CA) coupled on-line with a capillary HPLC (Hewlett-Packard
Model 1090A modified for capillary chromatography, as described in
Ref. 26) was used for peptide sequencing. A 60-min linear gradient (flow
rate 1.7 ml/min) was used from 0–100% solvent B, where solvent A was
0.1% v/v aqueous trifluoroacetic acid and solvent B was 0.1% aqueous
trifluoroacetic acid in 60% acetonitrile. The electrospray parameters
were as follows: spray voltage, 4.5 kV; sheath gas and auxiliary gas flow
rates, 5 and 30 (arbitrary value), respectively; capillary temperature,
150 °C; capillary voltage, 20 V; and tube lens offset, 16 V. The sheath
liquid used was 2-methoxyethanol (99.9% HPLC grade) delivered at a
flow rate of 3 ml/min. The electron multiplier was set to 2860 V, and the
trap was allowed a maximum injection time of up to 200 ms. After
acquiring one scan in MS, the most intense ion in that spectrum above
a threshold of 1 3 105 was isolated for subsequent zoom scan and then
collision-induced dissociation in the following scans. The dissociation
energy was set to 55%.
Protein/Peptide Identification—The sequences of individual peptides
were identified using the SEQUEST algorithm, incorporated into the
Finnigan-MAT BIOWORKS software to correlate the uninterpreted
collision-induced dissociation spectra with amino acid sequences in the
OWL protein data base (27).
RESULTS
In the present study we have focused on protein phosphoryl-
ation as an assay for insulin signal transduction and action for
several reasons. First, insulin is known to regulate a number of
downstream actions via protein phosphorylation, including the
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synthesis of lipid, glycogen, and protein. Second, a number of
reagents that modulate protein phosphorylation including
phosphatase inhibitors like okadaic acid have profound effects
on insulin action (28). Finally, it is relatively simple using
metabolic labeling to conduct a random large scale analysis of
changes in protein phosphorylation in response to certain
treatments. To increase the sensitivity of detection, analysis
was performed on subcellular fractions rather than whole cell
lysates, a technique first applied to adipocytes by Avruch et al.
(29, 30). In these early studies, resolution of 32P-labeled phos-
phoproteins by SDS-polyacrylamide gel electrophoresis re-
vealed only one insulin-stimulated phosphoprotein of 123 kDa,
which likely corresponds to ATP-citrate lyase (30). In the cur-
rent study, we have utilized 2-DE to achieve higher resolution
of 32P-labeled phosphoproteins present in subcellular fractions
of adipocytes. The use of 2-DE to resolve 32P-labeled phospho-
proteins has been previously reported (31, 32), albeit not in
conjunction with subcellular fractionation. By combining radio-
labeling with subcellular fractionation and 2-DE, we hoped to
attain the resolution required to study the phosphorylation of
low abundance phosphoproteins.
Three subcellular fractions have been studied in detail as
indicated below. The rationale for selecting these particular
fractions is based on our previous observation that the PM
fraction contains the insulin and PDGF receptors, whereas the
HSP fraction is enriched in IRS1 (18). In response to PDGF,
PI3K is mainly recruited to the PM fraction, whereas in re-
sponse to insulin it is recruited to the HSP fraction. Therefore,
these different fractions potentially represent discrete loci for
the assembly of signaling complexes. We have also studied the
cytosolic fraction because it is also known to contain many
signaling molecules including MAP kinase and PKB.
Insulin-stimulated Protein Phosphorylation in the High
Speed Pellet and Cytosol Fractions—Initially we studied the
polypeptide composition of PM, HSP, and cytosol fractions iso-
lated from adipocytes. Using 2-DE and silver staining we iden-
tified .200 individual silver-stained spots/fraction (21). Most of
the proteins resolved by this technique were in the molecular
mass range of 20–120 kDa consistent with previous studies
using this approach (31). Hence, it is unlikely that proteins
outside this range including IRS1 and IRS2 would have been
resolved. The overall pattern of silver-stained spots was quite
different between the three fractions studied, consistent with
the fact that they comprise distinct intracellular components
(21). We were unable to detect any effect of insulin on the
polypeptide composition among these fractions. Between 50
and 300 distinct phosphoprotein spots were detected in the PM,
HSP, and cytosol fractions, and the overall pattern of these
spots was significantly different between the different frac-
tions. In agreement with previous studies (29, 30, 32), the
phosphorylation of the majority of these spots was unaffected
by insulin treatment (Figs. 1 and 2). However, quantitative
analysis of five separate experiments showed that insulin con-
sistently and significantly increased the phosphorylation of at
least 18 spots (Figs. 1 and 2).
To further ascertain that our phosphoprotein mapping tech-
nique accurately reflects cellular phosphorylation, we first ex-
amined a well characterized insulin target, MAP kinase. Using
an antibody specific for both the p42 and p44 MAP kinase
isoforms we first showed that these proteins were enriched in
the cytosol fraction of 3T3-L1 adipocytes (data not shown).
Analysis of the cytosol fraction by 2-DE followed by immuno-
blotting allowed resolution of several immunoreactive spots
migrating at the appropriate mass and pI of p44 and p42 MAP
kinase (Fig. 3A). Following insulin stimulation, there was a
leftward shift toward acidic pI for both p42 and p44 MAP
kinase (Fig. 3B), and these spots could now also be detected
using a phospho-MAP kinase antibody (Fig. 3D). Furthermore,
32P-labeled spots were detected at the same position as the
pI-shifted MAP kinase spots, but only in the insulin-stimulated
cytosol fraction (C65, C79, Fig. 1). These results demonstrate
that our technique is sensitive enough to detect changes in the
phosphorylation of low abundance signaling proteins.
Similar studies to those described above were performed to
determine if our screen could detect another major downstream
target of insulin, PKB. PKB phosphorylation is induced by
insulin in a PI3K-dependent manner (33). We have recently
reported that PKBb is the main isoform expressed in 3T3-L1
adipocytes, and it is enriched in the cytosol (8). To better
resolve proteins in the molecular mass and pI range of PKB (58
kDa/pI 5.9), it was necessary to perform our mapping studies in
buffer containing reduced levels of bovine serum albumin. Un-
der these conditions, a row of 32P-labeled spots was observed in
the region of the gel corresponding to the predicted position of
PKB (Fig. 4A). Insulin increased the phosphorylation of five of
these spots (compare Fig. 4, A and B). To determine if any of
these spots corresponded to PKBb, 32P-labeled cytosol fractions
from basal or insulin-treated cells were analyzed by 2-DE and
immunoblotting with a PKBb antibody (Fig. 4, C and D). In the
basal state, the PKBb antibody detected four distinct spots
(spots 0–3, Fig. 4C). In agreement with previous results (8),
spots 1 and 2 overlapped with 32P-labeled spots, representing
constitutively phosphorylated PKBb (Fig. 4, A and C). Insulin
FIG. 1. Phosphorylation maps of the cytosol fraction. 3T3-L1
adipocytes were labeled with 32P and incubated in the absence (A) or
presence (B) of insulin for 15 min. Cells were homogenized and frac-
tionated to generate a cytosol fraction, and this was subjected to 2-DE
and autoradiography. Five separate experiments were analyzed quan-
titatively for insulin-regulated phosphoprotein spots. These are marked
with spot numbers preceded by C for cytosol, and the results are
summarized in Table I. IEF, isoelectric focusing.
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stimulation increased the phosphorylation of spots 1–4 (Fig. 4,
A and B), decreased the immunoreactivity of spots 0 and 1, and
increased the immunoreactivity of spots 2–4 (Fig. 4, C and D).
Other phosphospots detected in this region did not overlap with
PKBb-immunoreactive spots (indicated by arrowheads in Fig.
4, A and B) and likely represent other phosphoproteins of
similar molecular mass and pI.
Effects of Insulin, PDGF, and Insulin Plus Wortmannin on
Protein Phosphorylation—The screen that we have designed to
identify a putative insulin-specific signaling pathway in adipo-
cytes is based on the fact that adipocytes express receptors for
PDGF, but PDGF does not activate glucose metabolism in these
cells (13, 14, 18). Furthermore, the PI3K inhibitor wortmannin
potently inhibits insulin regulation of metabolism. Thus, we
reasoned that this technique should enable us to resolve an
insulin-specific, PDGF-insensitive pathway by comparing the
effects of these different compounds on protein phosphoryla-
tion. A series of experiments were performed to compare the
protein phosphorylation pattern between insulin, PDGF, and
insulin plus wortmannin treatment. A quantitative analysis of
five different experiments was performed using Melanie soft-
ware to compare the extent of phosphorylation of individual
spots with the different treatments. These data are summa-
rized in Tables I and II, with the corresponding spots indicated
in Figs. 1 and 2. Insulin increased the phosphorylation of 18
different spots and decreased the phosphorylation of one row of
phosphospots (C12). The insulin-dependent increase in phos-
phorylation among these different spots ranged in magnitude
from 2-fold (C69, C95, H62, and H74) to .10-fold (C65, C79,
H56, and H75) over basal. Some of the spots appeared to be
phosphorylated under basal conditions (C2, C69, C95, H62, and
H74). In fact for some of these there appeared to be a row of
phosphospots that underwent a further leftward shift in re-
sponse to insulin. This was most clearly observed for PKBb
(Fig. 4). However, in other cases we were unable to detect any
significant phosphorylation under basal conditions (C65, C77,
C79, H56, and H59). For these reasons it was difficult to pre-
cisely quantify the fold increase above basal in response to
either insulin or PDGF, and so we have quantified each spot as
a percentage of that observed in the presence of insulin.
Analysis of all the insulin-stimulated phosphoproteins in
relation to their response to PDGF and wortmannin revealed
that each of these spots fell into one of several different cate-
gories (see Fig. 5 for summary). Certain spots underwent a
comparable increase in phosphorylation in response to both
insulin and PDGF (C65, C77, C79, C95, H48, and H74). The
majority of spots, however, were only phosphorylated in re-
sponse to insulin (C2, C22, C49, C69, H38, H46, H56, H59,
H60, H62, H72, H74, and H75). We did observe a slight in-
crease in phosphorylation with PDGF for some of these pro-
teins (C49, H46, H72, and H75) but this was not a reproducible
phenomenon and the magnitude of this effect was less than
that observed in response to insulin. Hence, these proteins
were categorized as PDGF-insensitive, although it is conceiva-
ble that further analyses may reveal that they are PDGF
responsive albeit to a lesser extent than insulin. Wortmannin
abolished the insulin-stimulated phosphorylation of 16 spots
but had no significant inhibitory effect on the insulin-induced
phosphorylation of C22 and H48. However, the protein corre-
sponding to H48 was also stimulated by PDGF and so does not
represent an insulin-specific phosphoprotein. In addition, the
FIG. 2. Phosphorylation maps of the HSP fraction. 3T3-L1 adi-
pocytes were labeled with 32P and incubated in the absence (A) or
presence (B) of insulin for 15 min. Cells were homogenized and frac-
tionated to generate a HSP fraction, which was analyzed by 2-DE and
autoradiography. Quantitative analysis was performed on five separate
experiments for insulin-regulated phosphoprotein spots. These are
marked with spot numbers preceded by H for HSP, and the results are
summarized in Table II. IEF, isoelectric focusing.
FIG. 3. Identification of C65 and C79 as p44 and p42 MAP
kinase. 3T3-L1 adipocytes were 32P-labeled and then incubated in the
absence (A, C, and E) or presence of insulin (B, D, and F) for 15 min.
Cytosol was isolated, subjected to 2-DE, and analyzed either by auto-
radiography (E and F) or by immunoblotting with (A and B) a pan-MAP
kinase antibody or (C and D) a phospho-MAP kinase antibody.
FIG. 4. Insulin induces PKBb phosphorylation. 3T3-L1 adipo-
cytes were 32P-labeled in Krebs-Ringer phosphate buffer containing
0.1% bovine serum albumin, and then left untreated (A and C) or
stimulated with insulin (B and D). Cytosol fractions (150 mg) were
analyzed by 2-DE and autoradiography (A and B) or immunoblotting
with a PKBb antibody (C and D). The corresponding region in cytosol
maps is indicated by the box in Fig. 1B.
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response to wortmannin for C22 was somewhat variable in that
in three experiments wortmannin had no effect on insulin-
stimulated C22 phosphorylation, whereas it caused complete
inhibition in two other experiments.
Analysis of the subcellular distribution of insulin-regulated
phosphoproteins suggested that insulin-specific (i.e. PDGF-in-
sensitive) phosphoproteins preferentially localized to the HSP,
with 62% found in this fraction (Fig. 5). On the other hand, only
30% of PDGF-sensitive phosphoproteins were in the HSP frac-
tion (Fig. 5). The preferential localization of insulin-specific
phosphoproteins in the HSP is consistent with the reported
lack of PDGF-stimulated PI3K activity in this fraction (13, 14,
18) and further suggest that some insulin signaling pathways
may be sequestered in a subcellular compartment, which frac-
tionates in the HSP.
Identification of C2 as ATP-citrate Lyase—In an attempt to
identify some of the insulin-specific phosphoproteins picked up
in our screen, we scaled up the isolation procedure as described
under “Experimental Procedures.” Several of our candidate
phosphospots were purified to Coomassie-stained bands, di-
gested with trypsin, and subjected to liquid chromatography-
MS. One of these spots contained sequences that correspond to
a protein previously described to undergo insulin-stimulated
phosphorylation. This protein, designated as C2 in our screen,
was ACL (Fig. 6 and Table III), an enzyme which catalyzes the
first step in fatty acid synthesis, the formation of acetyl-CoA
(34, 35). Five differentially charged forms of phosphorylated
ACL were consistently observed in the cytosol from insulin-
stimulated adipocytes (Fig. 6B). A low level of ACL phospho-
rylation was observed in the basal state; however, the spots
TABLE I
Characteristics of insulin-regulated cytosolic phosphoproteins
Statistical analysis was performed on insulin-stimulated cytosolic spots, as indicated in Fig. 1. Intensities are expressed as a percentage of the
corresponding insulin-stimulated spot. The observed molecular mass and pI of insulin-stimulated phosphoproteins were calculated from identified
landmark spots, by the Melanie II software. Spots which are PDGF-insensitive and wortmannin-sensitive (as determined by paired t tests) are
shown in bold. MAPK, mitogen-activated protein kinase.
Spot no. Molecular mass pI
Relative value
na Identity
Basal PDGF Wortmannin/Insulin
kDa % of insulin
C2 121 6.35–6.73 21.5 6 7.2b 23.7 6 9.5 25.4 6 9.2 4 ACL
C22 71 6.18 16.0 6 13.7b 39.7 6 26.5 65.3 6 39.4d 4
C49 48 6.22 10.5 6 7.8b 38.9 6 20.4 16.7 6 12.8 4
C65 44 6.01 3.9 6 4.4b 71.4 6 39.1c 0 4 MAPK
C69 43 5.50 30.8 6 12.7b 28.2 6 18.4 13.8 6 17.0 3
C77 41 6.27 9.2 6 10.3b 63.0 6 14.3c 2.6 6 2.9 4 MAPK
C79 41 6.21 0b 127.2 6 36.0c 0 4
C95 35 6.17 42.0 6 11.0b 126.3 6 39.7c 39.2 6 16.7 4
C12 95 6.95 171.9 6 3.6b 190.1 6 67.9 166.8 6 43.6 4 EF2
a n 5 number of data sets used for statistical analysis.
b p , 0.05 compared to insulin values (paired t test).
c p , 0.05 compared to basal values (paired t test).
d p . 0.05 compared to insulin values (paired t test).
TABLE II
Characteristics of insulin-regulated HSP phosphoproteins
Statistical analysis was performed on insulin-stimulated HSP spots, as indicated in Fig. 2. Intensities are expressed as a percentage of the
corresponding insulin-stimulated spot. The observed molecular mass and pI of insulin-stimulated phosphoproteins were calculated from identified
landmark spots, by the Melanie II software. Spots which are PDGF-insensitive and wortmannin-sensitive (as determined by paired t tests) are
shown in bold.
Spot no. Molecular mass pI
Relative value
na
Basal PDGF Wortmannin/Insulin
kDa % of insulin
H38 61 6.16 9.2 6 10.6b 19.9 6 24.4 0 3
H46 56 6.15 20.6 6 11.0b 53.6 6 17.6 26.8 6 16.5 3
H48 49 4.86 24.3 6 15.1b 86.7 6 20.1c 73.9 6 17.0d 5
H56 48 6.22 1.5 6 1.7b 13.0 6 8.7 1.8 6 2.0 4
H59 45 6.26 7.5 6 8.4b 17.7 6 15.5 15.7 6 18.2 4
H60 43 6.34 15.8 6 17.6b 12.3 6 11.1 15.8 6 18.3 4
H62 42 6.43 40.1 6 19.6b 54.4 6 2.3 23.5 6 14.6 3
H72 40 6.18 10.0 6 11.2b 50.3 6 16.1 11.6 6 11.7 4
H74 39 6.27 37.2 6 7.0b 79.0 6 17.0c 41.7 6 17.6 5
H75 38 6.57 6.2 6 4.4b 32.8 6 13.7 7.0 6 3.0 4
a n 5 number of data sets used for statistical analysis.
b p , 0.05 compared to insulin values (paired t test).
c p , 0.05 compared to basal values (paired t test).
d p . 0.05 compared to insulin values (paired t test).
FIG. 5. Insulin-specific phosphoproteins preferentially local-
ize to the HSP fraction. Insulin-regulated phosphoproteins (summa-
rized in Tables I and II) were grouped by subcellular location (cytosol
versus HSP), sensitivity to PDGF stimulation, and the effect of wort-
mannin on insulin-induced phosphorylation.
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phosphorylated varied between the two most acidic spots (Fig.
6A, n 5 2) and the three most basic spots (not shown, n 5 3).
Insulin caused a 5-fold increase in ACL phosphorylation, which
was inhibited by wortmannin pretreatment (Table I and Fig.
6). The identification of this protein in our screen provides
further validation for the integrity of the screen, because based
on previous studies (34, 35) we would have expected this mol-
ecule to have been resolved using this type of approach.
Insulin Decreases the Phosphorylation of Elongation Factor
2—A row of constitutively phosphorylated spots that under-
went insulin-dependent dephosphorylation (C12) was identi-
fied by liquid chromatography-MS as translation elongation
factor 2 (EF2, Fig. 6, Table III). EF2 is a GTP-binding protein
that mediates the translocation step in translation elongation
and is completely inactivated when phosphorylated (reviewed
in Ref. 36). It was recently reported that insulin decreases EF2
phosphorylation in Chinese hamster ovary cells overexpressing
the insulin receptor (37) and in adipocytes (38). In the present
study, we have also observed a significant insulin-dependent
decrease in EF2 phosphorylation in 3T3-L1 adipocytes (Fig. 6).
The magnitude of the decrease (2-fold) observed in our study is
comparable to that reported previously (38). In contrast to that
study, however, 3 distinct phosphospots were resolved by 2-DE
(Fig. 6), consistent with the reported three phosphorylation
sites in EF2 (39). Insulin-induced dephosphorylation was not
specific for any charged isoform of EF2, and was prevented by
wortmannin pretreatment (Fig. 6). PDGF had no significant
effect on EF2 phosphorylation (Fig. 6).
DISCUSSION
The purpose of these studies was to test the hypothesis that
insulin activates glucose metabolism by activating the PI3K/
PKB pathway as well as another PI3K-independent pathway.
Whereas overwhelming evidence has been presented to impli-
cate a role for PI3K/PKB in this pathway, it has recently been
suggested that activation of PI3K may not be sufficient to
replicate the effects of insulin on glucose metabolism. Perhaps
the most provocative study in favor of a PI3K-independent
pathway was performed by Tsien and colleagues (19) who
showed that a membrane-permeable PIP3 analog had no effect
on glucose transport in adipocytes per se. However, this com-
pound was capable of suppressing the effects of a PI3K inhib-
itor, wortmannin, on insulin-stimulated glucose transport (19).
Hence, this would support a role for PI3K and an additional
PI3K-independent pathway in the regulation of glucose metab-
olism by insulin. In an effort to identify constituents of this
so-called insulin-activated PI3K-independent pathway, we
have used two-dimensional gel mapping of phosphoproteins in
3T3-L1 adipocytes. This screen relies on several major assump-
tions: (a) the alternate pathway involves, at some level, protein
phosphorylation/dephosphorylation; (b) wortmannin does not
inhibit the alternate pathway, which based on previous studies
by Tsien and colleagues (19) seems likely; (c) that if such
phosphoproteins do exist they will be present in sufficient
abundance to be resolved by subcellular fractionation and
2-DE; and (d) PDGF will not activate this pathway because it
activates PI3K, yet does not stimulate glucose uptake in
adipocytes.
Using a subtraction-based analysis employing 2-DE, we find
no evidence to support the existence of an insulin-stimulated
PI3K-independent pathway involving protein phosphorylation
in adipocytes. We detected at least 18 distinct spots that likely
correspond to discrete proteins whose phosphorylation was in-
creased by insulin. PDGF increased the phosphorylation of six
of these proteins, whereas it had no significant effect on the
remaining 12 spots (Fig. 5). Remarkably, wortmannin caused
complete inhibition of the phosphorylation of 11 of these 12
insulin-specific phosphoproteins. Hence, in light of the above
assumptions concerning the technique used here, these data
provide compelling support in favor of the existence of an
insulin-specific signaling pathway in adipocytes where almost
all of the protoconstituents of this pathway are likely down-
stream of PI3K.
If there is no insulin-specific PI3K-independent pathway in
adipocytes, this raises the important question as to how insu-
lin, but not PDGF, activates a unique subset of downstream
phosphoproteins when both growth factors appear to activate
PI3K. One possibility that we (18) and others (13, 14) favor is
that insulin activates PI3K in a unique location within the cell
and that this may allow the enzyme to access a unique reper-
toire of downstream proteins. We have gathered evidence in
favor of this hypothesis in the present study because we ob-
served that most of the insulin-specific phosphoproteins were
localized to the same subcellular fraction as the insulin-de-
pendent PI3K activity (Fig. 5). Most notably the PDGF-stimu-
lated PI3K activity is found in a separate fraction (13, 14, 18).
Another possibility that is perhaps not mutually exclusive to
that described above is that insulin and PDGF may activate
unique PI3K isoforms. This would not be surprising because we
have recently observed that insulin preferentially activates the
PKBb isoform in adipocytes (8). Yet another possibility re-
volves around the fact that PI3K possesses both lipid and
protein kinase activities. It has recently been reported that the
protein kinase activity of PI3K may selectively regulate mito-
gen-activated protein kinase activity, whereas its lipid kinase
activity may selectively activate PKB (40). Wortmannin binds
to the ATP binding site in PI3K and so inhibits both the protein
and lipid kinase activities. Hence this would potentially ex-
plain why in the present studies we observe inhibition of al-
most all insulin-specific phosphoproteins by wortmannin. It
remains possible that the protein kinase activity of PI3K me-
diates the so-called alternate pathway because PIP3 analogs
only partially rescued the wortmannin block of insulin-stimu-
lated glucose uptake in adipocytes (19). Recent experiments
using plasma membrane recruitment of green fluorescent pro-
tein-tagged ADP ribosylation factor nucleotide-binding site
opener (ARNO) as an assay for PIP3 production have failed to
find a significant effect of PDGF in adipocytes (41). This sug-
gests that although PI3K is recruited to the PDGF receptor in
FIG. 6. Insulin regulates the phosphorylation of C2 (ATP-cit-
rate lyase) and C12 (elongation factor 2). The basic, high molecular
mass region of cytosol phosphorylation maps from a representative
experiment is shown for basal (A), insulin-stimulated (B), PDGF-stim-
ulated (C), and wortmannin-plus-insulin-treated (D) adipocytes. The
rows of phosphospots corresponding to C2 and C12 are indicated. E and
F, the phosphorylation of C2 and C12 was quantitated from four sepa-
rate experiments and expressed as a percentage of the insulin-stimu-
lated (E) or basal (F) value. B, basal; I, insulin-stimulated; P, PDGF-
stimulated; W/I, wortmannin-plus-insulin-treated.
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response to PDGF in these cells (13, 14, 18), for some reason the
accumulation of PIP3 is blunted. Consistent with this, we have
recently reported that PDGF does not induce the phosphoryl-
ation or membrane translocation of PKBb in adipocytes (8).
This failure to stimulate PIP3 levels may be because of either a
block in production, possibly because the PDGF receptor does
not have access to phosphatidylinositol 4,5-bisphosphate, or to
an increased degradation of PIP3. In the case of the latter, it is
conceivable that the PDGF receptor binds a phospholipid phos-
phatase that selectively hydrolyses PIP3 produced in response
to PDGF, but not other ligands such as insulin. Despite the
inability of PDGF to increase PIP3 levels in adipocytes, it seems
clear from the present studies that PDGF stimulates the pro-
tein kinase activity of PI3K, because we observed a marked
increase in MAP kinase activity in response to both insulin and
PDGF, and this was inhibited by wortmannin (Table I). Thus,
it seems plausible that both the lipid and protein kinase activ-
ities of PI3K augment separate downstream signaling path-
ways in adipocytes, and both may be required to activate glu-
cose metabolism.
The present studies have clearly resolved a number of pro-
teins that are insulin-specific and wortmannin-sensitive and
thus constitute excellent candidates for downstream molecules
in insulin action. We have attempted to characterize many of
these proteins using liquid chromatography-MS; however, with
the exception of two proteins (Table III) the success of these
studies has been limited. This is due in part to inadequate
resolution of the preparative 2-DE system because many of the
spots identified contain .5–9 separate polypeptides (data not
shown). Thus, in order to extend these studies it may be nec-
essary to incorporate additional purification steps prior to
2-DE. It is also possible that many of the proteins we are
working with are very low abundance necessitating a much
larger scale than has been currently employed. Nevertheless in
view of the potential importance of some of the molecules
identified here, additional experiments are probably war-
ranted. The identification of ATP-citrate lyase as one of our
candidate proteins in part validated the use of this technique
because this protein is known to be phosphorylated by insulin
in a wortmannin-sensitive manner. This result also indicates
that this approach will enable us to achieve nonselective iden-
tification of both signaling proteins such as MAP kinase and
PKB (Figs. 3 and 4) as well as metabolic machinery (Fig. 6).
Furthermore, this approach can be used to detect both in-
creases and decreases in protein phosphorylation both of which
are affected by insulin. The only significant protein dephospho-
rylation event we were able to detect corresponded to the other
protein we were able to positively identify by MS and that was
eucaryotic elongation factor 2 (Table III and Fig. 6). This pro-
tein is a key regulatory determinant of mRNA translation, and
this process is known to be influenced by insulin stimulation.
To complement the recent studies reporting insulin-dependent
EF2 dephosphorylation, our data further suggest that dephos-
phorylation of EF2 is wortmannin-sensitive and PDGF-insen-
sitive in adipocytes.
In summary, we have identified a number of proteins that
are phosphorylated in an insulin-specific and wortmannin-sen-
sitive manner. The absence of insulin-specific wortmannin-
insensitive proteins calls into question the existence of a PI3K-
independent pathway in adipocytes. Recent studies also
suggest that PI3K is involved in insulin regulation of metabo-
lism in the liver (42, 43). Interestingly, in hepatocytes insulin
also stimulates PI3K activity in a fraction similar to the high
speed pellet fraction of adipocytes (43). Indeed many of the
insulin-specific phosphoproteins we have mapped in the cur-
rent study are enriched in the HSP fraction that also contains
the insulin responsive IRS proteins (13, 14, 18, 43), adding
further support to the concept that localization of signaling
molecules may play an important role in their specific function.
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